Actinium
Pharmaceuticals is engaged in development and commercialization of immunotherapeutics for the treatment of cancer... Read moreActinium
Pharmaceuticals is engaged in development and commercialization of immunotherapeutics for the treatment of cancer... Read more
1997
PublicIndependent CompanyNYSEATNM
News
Apr 03, 2025
Benzinga
Actinium: ROSEN, A LONGSTANDING LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATNM
Apr 02, 2025
Benzinga
Actinium: ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
Apr 01, 2025
Marketscreener
Actinium: ATNM Bronstein, Gewirtz & Grossman LLC Announces that Actinium Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Apr 01, 2025
Owler
Actinium Pharmaceuticals, Inc.: Actinium's employee count changed from 49 in Mar 2024 to 37 in Dec 2024
Mar 31, 2025
Benzinga
Actinium: Actinium Pharmaceuticals, Inc. Shareholder Notice: Robbins LLP Reminds Investors of the Class Action Against ATNM
Mar 31, 2025
Marketscreener
Actinium: Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
Mar 27, 2025
PR Newswire
Press Release: Actinium : Actinium Pharmaceuticals Announces ATNM-400 a Novel Non-PSMA Targeting First in Class Prostate Cancer Radiotherapy Leveraging Actinium-225
Mar 26, 2025
Pharmabiz
Actinium: Actinium Pharma inks supply agreement with Eckert & Ziegler for Ac225 radioisotope to support comprehensive development activities
Mar 22, 2025
Pharmabiz
Actinium: Actinium Pharma inks research pact with Memorial Sloan Kettering to support further clinical expansion of ActimabA's backbone therapy strategy
Nov 18, 2024
FinanzNachrichten
Actinium: Actinium Pharma Q3 Loss Narrows
Actinium Competitors
1
2
3
4
5
6
7
8
9
10